Cisplatin Eligibility and Maintenance Therapy in Metastatic Urothelial Carcinoma

Opinion
Video

The expert panel discusses how treatment strategies change based on cisplatin eligibility and the role of maintenance therapy in metastatic urothelial carcinoma.

Related Videos
Video 16 - "Neoadjuvant Approach in RAI-R-DTC"
Video 15 - "Addressing Unmet Needs and Challenges in RAI-R-DTC Treatment"
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer
Kathryn Beckermann, MD, PhD
Robert Wang, MD, of Fox Chase Cancer Center
A panel of 4 experts on colorectal cancer
A panel of 4 experts on colorectal cancer
Alexander Kutikov, MD, FACS, of Fox Chase Cancer Center
Related Content
Robert Wang, MD

Fox Chase Researchers Examine Alternative Methods of Specialized Imaging Scans for Kidney Masses

May 8th 2024
Article
Carrie L. Kitko, MD, associate professor, pediatrics, medical director, the Pediatric Stem Cell Transplantation Program, the Ingram Professor of Pediatric Oncology, Monroe Carell Jr. Children’s Hospital at Vanderbilt; Sagar S. Patel, MD, director, Communications and Media Relationships, the Division of Hematology, the University of Utah Huntsman Cancer Institute

Kitko and Patel Emphasize the Importance of GVHD Research and Awareness

February 19th 2024
Podcast
FDA Accepts BLA for Subcutaneous Nivolumab in Advanced or Metastatic Solid Tumors

FDA Accepts BLA for Subcutaneous Nivolumab in Advanced or Metastatic Solid Tumors

May 6th 2024
Article
Yara Abdou, MD

Abdou Spotlights Factors Influencing ADC Treatment Selection in Breast Cancer

December 7th 2023
Podcast
Neli Ulrich, PhD, MS, professor, Population Health Sciences, chief scientific officer, executive director, Comprehensive Cancer Center, Huntsman Cancer Institute, the University of Utah

Utah Governor’s Medal Given to Neli Ulrich, PhD, MS, for Outstanding Research and Leadership

May 1st 2024
Article
Samer A. Srour, MB ChB, MS

Early Responses With CTX130 Renew Hope for Anti-CD70 CAR T-Cell Therapy in Advanced RCC

April 29th 2024
Article